Literature DB >> 31189431

Magnetic Resonance Imaging Reveals Distinct Roles for Tissue Transglutaminase and Factor XIII in Maternal Angiogenesis During Early Mouse Pregnancy.

Gadi Cohen1, Ron Hadas1, Rachele Stefania2, Amerigo Pagoto2, Shifra Ben-Dor3, Fortune Kohen1, Dario Longo2, Michal Elbaz4, Nave Dekel1, Eran Gershon4, Silvio Aime2, Michal Neeman1.   

Abstract

OBJECTIVE: The early embryo implantation is characterized by enhanced uterine vascular permeability at the site of blastocyst attachment, followed by extracellular-matrix remodeling and angiogenesis. Two TG (transglutaminase) isoenzymes, TG2 (tissue TG) and FXIII (factor XIII), catalyze covalent cross-linking of the extracellular-matrix. However, their specific role during embryo implantation is not fully understood. Approach and
Results: For mapping the distribution as well as the enzymatic activities of TG2 and FXIII towards blood-borne and resident extracellular-matrix substrates, we synthetized selective and specific low molecular weight substrate analogs for each of the isoenzymes. The implantation sites were challenged by genetically modifying the trophoblast cells in the outer layer of blastocysts, to either overexpress or deplete TG2 or FXIII, and the angiogenic response was studied by dynamic contrast-enhanced-magnetic resonance imaging. Dynamic contrast-enhanced-magnetic resonance imaging revealed a decrease in the permeability of decidual vasculature surrounding embryos in which FXIII were overexpressed in trophoblast cell. Reduction in decidual blood volume fraction was demonstrated when either FXIII or TG2 were overexpressed in embryonic trophoblast cell and was elevated when trophoblast cell was depleted of FXIII. These results were corroborated by histological analysis.
CONCLUSIONS: In this study, we report on the isoenzyme-specific roles of TG2 and FXIII during the early days of mouse pregnancy and further reveal their involvement in decidual angiogenesis. Our results reveal an important magnetic resonance imaging-detectable function of embryo-derived TG2 and FXIII on regulating maternal angiogenesis during embryo implantation in mice.Visual Overview: An online visual overview is available for this article.

Entities:  

Keywords:  blood volume; embryo implantation; factor XIII; magnetic resonance imaging; transglutaminase

Mesh:

Substances:

Year:  2019        PMID: 31189431      PMCID: PMC6656598          DOI: 10.1161/ATVBAHA.119.312832

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  48 in total

1.  Factor XIII of blood coagulation as a nuclear crosslinking enzyme.

Authors:  R Adány; H Bárdos; M Antal; L Módis; A Sárváry; S Szücs; I Balogh
Journal:  Thromb Haemost       Date:  2001-05       Impact factor: 5.249

2.  Modulation of the pharmacokinetics of macromolecular contrast material by avidin chase: MRI, optical, and inductively coupled plasma mass spectrometry tracking of triply labeled albumin.

Authors:  Hagit Dafni; Assaf Gilead; Nava Nevo; Raya Eilam; Alon Harmelin; Michal Neeman
Journal:  Magn Reson Med       Date:  2003-11       Impact factor: 4.668

3.  Recurrent miscarriage and long-term thrombosis risk: a case-control study.

Authors:  S Quenby; R G Farquharson; F Dawood; A M Hughes; J Topping
Journal:  Hum Reprod       Date:  2005-03-17       Impact factor: 6.918

4.  Identification of preferred substrate sequences for transglutaminase 1--development of a novel peptide that can efficiently detect cross-linking enzyme activity in the skin.

Authors:  Yoshiaki Sugimura; Masayo Hosono; Miyako Kitamura; Tatsuya Tsuda; Kiyofumi Yamanishi; Masatoshi Maki; Kiyotaka Hitomi
Journal:  FEBS J       Date:  2008-11       Impact factor: 5.542

5.  Chorioallantoic placenta formation in the rat: II. Angiogenesis and maternal blood circulation in the mesometrial region of the implantation chamber prior to placenta formation.

Authors:  A O Welsh; A C Enders
Journal:  Am J Anat       Date:  1991-12

6.  Uterine DCs are crucial for decidua formation during embryo implantation in mice.

Authors:  Vicki Plaks; Tal Birnberg; Tamara Berkutzki; Shay Sela; Adi BenYashar; Vyacheslav Kalchenko; Gil Mor; Eli Keshet; Nava Dekel; Michal Neeman; Steffen Jung
Journal:  J Clin Invest       Date:  2008-11-20       Impact factor: 14.808

Review 7.  Molecular cues to implantation.

Authors:  S K Dey; H Lim; Sanjoy K Das; Jeff Reese; B C Paria; Takiko Daikoku; Haibin Wang
Journal:  Endocr Rev       Date:  2004-06       Impact factor: 19.871

8.  Immunohistochemical localization of tissue transglutaminase and Bcl-2 in rat uterine tissues during embryo implantation and post-partum involution.

Authors:  M Piacentini; F Autuori
Journal:  Differentiation       Date:  1994-06       Impact factor: 3.880

9.  Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.

Authors:  John G Doench; Nicolo Fusi; Meagan Sullender; Mudra Hegde; Emma W Vaimberg; Jennifer Listgarten; Katherine F Donovan; Ian Smith; Zuzana Tothova; Craig Wilen; Robert Orchard; Herbert W Virgin; David E Root
Journal:  Nat Biotechnol       Date:  2016-01-18       Impact factor: 54.908

10.  Unraveling CRISPR-Cas9 genome engineering parameters via a library-on-library approach.

Authors:  Raj Chari; Prashant Mali; Mark Moosburner; George M Church
Journal:  Nat Methods       Date:  2015-07-13       Impact factor: 28.547

View more
  2 in total

1.  Application of Dynamic Contrast Enhanced Magnetic Resonance Imaging to Evaluate Angiogenic Response and Vascular Permeability.

Authors:  Mary C Wallingford; Tomo Tarui; Nirmala Jayaraman; Gordon S Huggins; Manjiri K Dighe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-07-24       Impact factor: 10.514

2.  F13A1 transglutaminase expression in human adipose tissue increases in acquired excess weight and associates with inflammatory status of adipocytes.

Authors:  M T Kaartinen; M Arora; S Heinonen; A Hang; A Barry; J Lundbom; A Hakkarainen; N Lundholm; A Rissanen; J Kaprio; K H Pietiläinen
Journal:  Int J Obes (Lond)       Date:  2020-11-21       Impact factor: 5.095

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.